[1] MINDLER K, OSTERTAG E, STEHLE T. The polyfunctional polysialic acid:a structural view[J]. Carbohydr Res, 2021, 507:108376.
[2] 吴剑荣, 彭星桥, 詹晓北. 聚唾液酸, 一种非GAGs、非免疫原性生物材料的应用研究进展[J]. 中国生物工程杂志, 2017, 37(12):96-102.
[3] COLLEY K J, KITAJIMA K, SATO C. Polysialic acid:biosynthesis, novel functions and applications[J]. Crit Rev Biochem Mol Biol, 2014, 49(6):498-532.
[4] 杨颜睿, 黄秋映, 杜宇航, 等. 基于多聚唾液酸的药物递送系统研究进展[J]. 中国药师, 2023, 26(12):491-498.
[5] 王梦花, 林小仙, 琚萌萌, 等. 唾液酸的制备和生物活性研究进展[J]. 药学研究, 2022, 41(9):600-604.
[6] 王欣, 关锋. 多聚唾液酸(PSA)及其修饰的神经粘附分子(PSA-NCAM)对肿瘤及细胞信号通路的影响[J]. 遗传, 2014, 36(8):739-746.
[7] JARAHIAN M, MAROFI F, MAASHI M S, et al. Re-expression of poly/oligo-sialylated adhesion molecules on the surface of tumor cells disrupts their interaction with immune-effector cells and contributes to pathophysiological immune escape[J]. Cancers, 2021, 13(20):5203.
[8] 周文波, 周长福. 神经细胞粘连分子和多聚唾液酸在神经发育和再生中的作用[J]. 生理科学进展, 1996, 2:118-122.
[9] SENKOV O, TIKHOBRAZOVA O, DITYATEV A. PSA-NCAM:synaptic functions mediated by its interactions with proteoglycans and glutamate receptors[J]. Int J Biochem Cell Biol, 2012, 44(4):591-595.
[10] WI-FELD J, ABOU ASSALE T, CUEVAS-RIOS G, et al. Therapeutic potential to target sialylation and SIGLECs in neurodegenerative and psychiatric diseases[J]. Front Neurol, 2024, 15:1330874.
[11] THIESLER H, BEIMDIEK J, HILDEBRANDT H. Polysialic acid and Siglec-E orchestrate negative feedback regulation of microglia activation[J]. Cell Mol Life Sci, 2021, 78(4):1637-1653.
[12] LIAO H, WINKLER J, WI-FELD J, et al. Low molecular weight polysialic acid prevents lipopolysaccharide-induced inflammatory dopaminergic neurodegeneration in humanized SIGLEC11 transgenic mice[J]. Glia, 2021, 69(12):2845-2862.
[13] ULM C, SAFFARZADEH M, MAHAVADI P, et al. Soluble polysialylated NCAM:a novel player of the innate immune system in the lung[J]. Cell Mol Life Sci, 2013, 70(19):3695-3708.
[14] 魏江洲, 周文丽, 郭婷婷, 等. 多聚唾液酸与多聚唾液酸转移酶[J]. 生命的化学, 2005, 25(6):473-475.
[15] RILLAHAN C D, ANTONOPOULOS A, LEFORT C T, et al. Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome[J]. Nat Chem Biol, 2012, 8(7):661-668.
[16] MOONS S J, ROSSING E, JANSSEN M A C H, et al. Structure-activity relationship of metabolic sialic acid inhibitors and labeling reagents[J]. ACS Chem Biol, 2022, 17(3):590-597.
[17] HEISE T, PIJNENBORG J F A, BÜLL C, et al. Potent metabolic sialylation inhibitors based on C-5-modified fluorinated sialic acids[J]. J Med Chem, 2019, 62(2):1014-1021.
[18] HUNTER C, GAO Z Z, CHEN H M, et al. Attenuation of polysialic acid biosynthesis in cells by the small molecule inhibitor 8-keto-sialic acid[J]. ACS Chem Biol, 2023, 18(1):41-48.
[19] LIAO S M, LIU X H, PENG L X, et al. Molecular mechanism of inhibition of polysialyltransferase domain (PSTD) by heparin[J]. Curr Top Med Chem, 2021, 21(13):1113-1120.
[20] LIAO S M, LU B, LIU X H, et al. Molecular interactions of the polysialytransferase Doma in (PSTD) in ST8Sia IV with CMP-sialic acid and polysialic acid required for polysialylation of the neural cell adhesion molecule proteins:an NMR study[J]. Int J Mol Sci, 2020, 21(5):1590.
[21] GIFFORD J L, HUNTER H N, VOGEL H J. Lactoferricin:a lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties[J]. Cell Mol Life Sci, 2005, 62(22):2588-2598.
[22] LU B, LIAO S M, LIANG S J, et al. The bifunctional effects of lactoferrin (LFcinB11) in inhibiting neural cell adhesive molecule (NCAM) polysialylation and the release of neutrophil extracellular traps (NETs)[J]. Int J Mol Sci, 2024, 25(9):4641.
[23] ECK R J, ELLING T, SUTTON A J, et al. Anticoagulants for thrombosis prophylaxis in acutely ill patients admitted to hospital:systematic review and network meta-analysis[J]. BMJ, 2022, 378:e070022.
[24] TANG N, LI H H, ZHANG L H, et al. A macromolecular drug for cancer therapy via extracellular calcification[J]. Angew Chem Int Ed, 2021, 60(12):6509-6517.
[25] COX E C, THORNLOW D N, JONES M A, et al. Antibody-mediated endocytosis of polysialic acid enables intracellular delivery and cytotoxicity of a glycan-directed antibody-drug conjugate[J]. Cancer Res, 2019, 79(8):1810-1821.
[26] STEIRER L M, MOE G R. An antibody to de-N-acetyl sialic acid containing-polysialic acid identifies an intracellular antigen and induces apoptosis in human cancer cell lines[J]. PLoS One, 2011, 6(11):e27249.
[27] LEHTI T A, PAJUNEN M I, JOKILAMMI A, et al. Design of a cytotoxic neuroblastoma-targeting agent using an enzyme acting on polysialic acid fused to a toxin[J]. Mol Cancer Ther, 2021, 20(10):1996-2007.
[28] MARTIN N T, WREDE C, NIEMANN J, et al. Targeting polysialic acid-abundant cancers using oncolytic adenoviruses with fibers fused to active bacteriophage borne endosialidase[J]. Biomaterials, 2018, 158:86-94.
[29] ZHANG Q X, LI S S, HE L, et al. A brief review of polysialic acid-based drug delivery systems[J]. Int J Biol Macromol, 2023, 230:123151.
[30] RODE B, ENDRES C, RAN C, et al. Large-scale production and homogenous purification of long chain polysialic acids from E. coli K1[J]. J Biotechnol, 2008, 135(2):202-209.
[31] LI X, GUAN S, LI H N, et al. Polysialic acid-functionalized liposomes for efficient honokiol delivery to inhibit breast cancer growth and metastasis[J]. Drug Deliv, 2023, 30(1):2181746.
[32] SHIM M K, NA J, CHO I K, et al. Targeting of claudin-4 by Clostridium perfringens enterotoxin-conjugated polysialic acid nanoparticles for pancreatic cancer therapy[J]. J Control Release, 2021, 331:434-442.
[33] XU J, LI Y A, CHEN Y, et al. Preparation and characterization of a novel polysialic acid/gelatin composite hydrogels cross-linked by tannic acid to improve wound healing after cesarean section dressing[J]. J Biomater Sci Polym Ed, 2021, 32(15):1927-1943.
[34] SUN J, TIAN Q J, LIU M, et al. Evaluation of the antitumor effect and immune response of micelles modified with a polysialic acid-D-α-tocopheryl polyethylene glycol 1000 succinate conjugate[J]. AAPS PharmSciTech, 2021, 22(7):223. |
